Immune control of pain

Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease

Intra-articular sustained-release colchicine is efficacious in an inflammatory arthritis rat model

Cytotoxic Response of CD4(+) T Cells Orchestrated by SLAMF4 in Rheumatoid Arthritis

Impairment of regulatory T cell stability in axial spondyloarthritis: role of EZH2 and pSTAT5

Crystalline silica exposure in patients with rheumatoid arthritis and systemic sclerosis: a nationwide cross-sectional survey

Are cleaning activities a source of exposure to crystalline silica in women with rheumatoid arthritis? A case-control study

Crowned dens syndrome

Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses

Serum Fatty Acid Profiles Are Associated with Disease Activity in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort

The exposome in rheumatoid arthritis

MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression

Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

Thoracic aorta involvement in giant cell arteritis: a case-control analysis of morphological data at diagnosis

Pistes urgentes dans le traitement de l’infection par le COVID-19 : cibler l’inflammation en aval pour prévenir un syndrome catastrophique

Origins of rheumatoid arthritis

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome

Microenvironment tailors nTreg structure and function

From coagulation to inflammation: novel avenues for treating rheumatoid arthritis with activated protein C

Air pollution as a determinant of rheumatoid arthritis

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Switch to a biosimilar: Whatever the cost?

Salt, inflammatory joint disease, and autoimmunity

IL-1 Vaccination Is Suitable for Treating Inflammatory Diseases

Nutrition and chronic inflammatory rheumatic disease

Do we need animal models to advance research on inflammatory joint disease?

Developments with experimental and investigational drugs for axial spondyloarthritis

Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection

Arthritis models: usefulness and interpretation

Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33

Developments with investigational Janus kinase inhibitors for rheumatoid arthritis

Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes

Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort

In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis

Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis

Novel Immunotherapeutic Avenues for Rheumatoid Arthritis

Personality modulates proportions of CD4(+) regulatory and effector T cells in response to socially induced stress in a rodent of wild origin

Red blood cell metabolomics identify ergothioneine as a key metabolite in DMARD-naïve rheumatoid arthritis and response to methotrexate

Methotrexate and rheumatoid arthritis associated interstitial lung disease

High prevalence of spondyloarthritis in sarcoidosis patients with chronic back pain

Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review

Calpains Released by T Lymphocytes Cleave TLR2 To Control IL-17 Expression

Mitral valve granulomatosis: A paradoxical reaction complicating etanercept treatment in rheumatoid arthritis. A case report

Integrating social and economic status in rheumatoid arthritis exposure studies

Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study

Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

Battle of the brains: A comparison of human and ChatGPT health editorials

Teriparatide for osteoporosis in patients with sarcoidosis: Report on risk-benefit ratio in four cases

Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study

Vitamin D supplementation in patients treated for sarcoidosis: Controversy or consensus?

Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review